We’re here to The ancient science of Ayurveda has as much relevance today as it did to people of ancient India, where it originated atleast 5000 years ago. In the 21st century we use Ayurvedic wisdom as a tool for balancing our lives – whether we want to have more energy, loose weight, improve our moods, or simply feel healthier.
Ayurveda is based on the principles of living in harmony with the cycles and rhythms of nature.
After India gained its independence in 1947, Ayurveda gained ground and new schools began to be established. Although Ayurveda remains a secondary system of healthcare in India, the trend towards complementary care is emerging, and Western and Ayurvedic physicians often work side by side. Before Ayurveda began its recent renewal in the West, it went through a period of decline in Indian when Western medical education became dominant during the era of British rule. Ayurveda became a second-class option used primarily by traditional medical practitioners and the poor.
Interest in Ayurveda, in the West began in the mid 1970s as Ayurvedic teachers from India began visiting the United States and Europe. By sharing their knowledge they have inspired a vast movement toward body-mind spirit medicine.
Today Ayurvedic colleges are opening throughout Europe, Australia and the United States.
Global community is now trying to find out the sustainable solutions to age related onset of fatal diseases across various healthcare systems. Can Ayurveda, the world’s most comprehensive, personalized, holistic and sustainable healthcare system provide solutions to substantially delay the age related pathogenesis? In other words if we do not suffer from a critical illness today, is it possible to remain healthy for substantial period of life or is it possible to increase health span?
Some caveats need to be made clear upfront. First, while the drug is aimed at addressing the challenges of advancing age, these efforts are not to be termed as anti-aging. The drug is not intended to increase the life span; rather it is aimed to increase the health span. Second, it dreams to develop a drug accessible to rich and poor alike. Meaning thereby that it should fulfil both the criteria of cost as well as ease of production.